▶ 調査レポート

小児神経芽細胞腫治療の世界市場（～2026年）
• 英文タイトル：Global Pediatric Neuroblastoma Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。小児神経芽細胞腫治療の世界市場（～2026年） / Global Pediatric Neuroblastoma Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY04196資料のイメージです。• レポートコード：MRC2-11QY04196
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は小児神経芽細胞腫治療のグローバル市場について調査・分析したレポートです。種類別（免疫療法、化学療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別小児神経芽細胞腫治療の競争状況、市場シェア
・世界の小児神経芽細胞腫治療市場：種類別市場規模 2015年-2020年（免疫療法、化学療法、その他）
・世界の小児神経芽細胞腫治療市場：種類別市場規模予測 2021年-2026年（免疫療法、化学療法、その他）
・世界の小児神経芽細胞腫治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界の小児神経芽細胞腫治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米の小児神経芽細胞腫治療市場分析：米国、カナダ
・ヨーロッパの小児神経芽細胞腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの小児神経芽細胞腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の小児神経芽細胞腫治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの小児神経芽細胞腫治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：United Therapeutics、Apeiron Biologics、Pfizer、Bayer、Baxter、Cellectar Biosciences、MacroGenics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.

Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market
The global Pediatric Neuroblastoma Treatment market size is projected to reach US$ 614.6 million by 2026, from US$ 582.8 million in 2020, at a CAGR of 5.0%% during 2021-2026.

Global Pediatric Neuroblastoma Treatment Scope and Market Size
Pediatric Neuroblastoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Neuroblastoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics
…

Market segment by Type, the product can be split into
Immunotherapy
Chemotherapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapy
1.4.3 Chemotherapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Pediatric Neuroblastoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2015-2026)
2.2 Global Pediatric Neuroblastoma Treatment Growth Trends by Regions
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatric Neuroblastoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatric Neuroblastoma Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Market Size
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.2.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2019
3.3 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.4 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.5 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2015-2020)
6.2 Pediatric Neuroblastoma Treatment Key Players in North America (2019-2020)
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2015-2020)
7.2 Pediatric Neuroblastoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

8 China
8.1 China Pediatric Neuroblastoma Treatment Market Size (2015-2020)
8.2 Pediatric Neuroblastoma Treatment Key Players in China (2019-2020)
8.3 China Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
8.4 China Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pediatric Neuroblastoma Treatment Market Size (2015-2020)
9.2 Pediatric Neuroblastoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
9.4 Japan Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pediatric Neuroblastoma Treatment Market Size (2015-2020)
10.2 Pediatric Neuroblastoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

11 India
11.1 India Pediatric Neuroblastoma Treatment Market Size (2015-2020)
11.2 Pediatric Neuroblastoma Treatment Key Players in India (2019-2020)
11.3 India Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
11.4 India Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pediatric Neuroblastoma Treatment Market Size (2015-2020)
12.2 Pediatric Neuroblastoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 United Therapeutics
13.1.1 United Therapeutics Company Details
13.1.2 United Therapeutics Business Overview
13.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
13.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020))
13.1.5 United Therapeutics Recent Development
13.2 Apeiron Biologics
13.2.1 Apeiron Biologics Company Details
13.2.2 Apeiron Biologics Business Overview
13.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
13.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.2.5 Apeiron Biologics Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
13.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
13.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Baxter
13.5.1 Baxter Company Details
13.5.2 Baxter Business Overview
13.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
13.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.5.5 Baxter Recent Development
13.6 Cellectar Biosciences
13.6.1 Cellectar Biosciences Company Details
13.6.2 Cellectar Biosciences Business Overview
13.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
13.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.6.5 Cellectar Biosciences Recent Development
13.7 MacroGenics
13.7.1 MacroGenics Company Details
13.7.2 MacroGenics Business Overview
13.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
13.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020)
13.7.5 MacroGenics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pediatric Neuroblastoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
Table 3. Ranking of Global Top Pediatric Neuroblastoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pediatric Neuroblastoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pediatric Neuroblastoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2015-2020)
Table 12. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pediatric Neuroblastoma Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Pediatric Neuroblastoma Treatment Players
Table 19. Global Pediatric Neuroblastoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pediatric Neuroblastoma Treatment Market Share by Players (2015-2020)
Table 21. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2019)
Table 22. Global Pediatric Neuroblastoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 25. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size Share by Type (2015-2020)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2015-2020)
Table 31. Global Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 35. North America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 37. North America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 41. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 43. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 47. China Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 49. China Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 53. Japan Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 55. Japan Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 59. Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 65. India Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 67. India Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pediatric Neuroblastoma Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2020)
Table 71. Central & South America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pediatric Neuroblastoma Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pediatric Neuroblastoma Treatment Market Share by Application (2015-2020)
Table 75. United Therapeutics Company Details
Table 76. United Therapeutics Business Overview
Table 77. United Therapeutics Product
Table 78. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 79. United Therapeutics Recent Development
Table 80. Apeiron Biologics Company Details
Table 81. Apeiron Biologics Business Overview
Table 82. Apeiron Biologics Product
Table 83. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 84. Apeiron Biologics Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Product
Table 93. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 94. Bayer Recent Development
Table 95. Baxter Company Details
Table 96. Baxter Business Overview
Table 97. Baxter Product
Table 98. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 99. Baxter Recent Development
Table 100. Cellectar Biosciences Company Details
Table 101. Cellectar Biosciences Business Overview
Table 102. Cellectar Biosciences Product
Table 103. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 104. Cellectar Biosciences Recent Development
Table 105. MacroGenics Company Details
Table 106. MacroGenics Business Overview
Table 107. MacroGenics Product
Table 108. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2015-2020) (Million US$)
Table 109. MacroGenics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapy Features
Figure 3. Chemotherapy Features
Figure 4. Others Features
Figure 5. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 10. Global Pediatric Neuroblastoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pediatric Neuroblastoma Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2019
Figure 15. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2019
Figure 17. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介
  • 小児放射線の世界市場（～2026年）
    Global Pediatric Radiology Market Size, Status and Forecast 2020-2026
    MRC2-11QY04197 2020年11月20日 97Pages
    当調査資料は小児放射線のグローバル市場について調査・分析したレポートです。種類別（超音波、X線、磁気共鳴画像法、核医学、コンピューター断層撮影）市場規模、用途別（小児超音波、放射線画像、小児X線、小児CTスキャン、小児MRI/胎児MRI、蛍光透視法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...
  • 小児脳腫瘍の世界市場（～2026年）
    Global Pediatric Brain Tumor Market Size, Status and Forecast 2020-2026
    MRC2-11QY04192 2020年11月20日 98Pages
    当調査資料は小児脳腫瘍のグローバル市場について調査・分析したレポートです。種類別（神経膠腫、混合神経膠腫、胚性腫瘍、脈絡叢乳頭腫/癌、非神経上皮組織発生腫瘍、髄膜腫瘍）市場規模、用途別（病院および診療所、医学研究センター、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...
  • 小児てんかん治療薬の世界市場（～2026年）
    Global Pediatric Epilepsy Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY04194 2020年11月20日 93Pages
    当調査資料は小児てんかん治療薬のグローバル市場について調査・分析したレポートです。種類別（良性ローランドてんかん、小児欠神てんかん、若年ミオクロニックてんかん、乳児けいれん、レノックス・ガストー症候群）市場規模、用途別（病院、神経内科センター、在宅医療施設、外来手術センター）市場規模、地域別（北米、...
  • OTC小児医療の世界市場（～2026年）
    Global OTC Pediatric Healthcare Market Size, Status and Forecast 2020-2026
    MRC2-11QY04115 2020年11月20日 97Pages
    当調査資料はOTC小児医療のグローバル市場について調査・分析したレポートです。種類別（胃腸、皮膚科、ENT、栄養/ビタミン、その他）市場規模、用途別（病院薬局、ドラッグストア/薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...
  • 小児画像の世界市場（～2026年）
    Global Pediatric Imaging Market Size, Status and Forecast 2020-2026
    MRC2-11QY04195 2020年11月20日 92Pages
    当調査資料は小児画像のグローバル市場について調査・分析したレポートです。種類別（超音波装置、磁気共鳴画像法（MRI）、電子コンピューター断層撮影（CT）、X線装置、その他）市場規模、用途別（病院、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • 小児整形外科インプラントの世界市場（～2026年）
    Global Pediatric Orthopedic Implant Market Insights and Forecast to 2026
    MRC2-11QY08802 2020年11月25日 115Pages
    当調査資料は小児整形外科インプラントのグローバル市場について調査・分析したレポートです。種類別（外傷・奇形、脊椎、スマートインプラント、スポーツ医学）市場規模、用途別（病院・診療所、在宅医療、外来診療センター、救急医療サービス（EMS））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...
  • 小児用ワクチンの世界市場（～2026年）
    Global Pediatric Vaccines Market Insights and Forecast to 2026
    MRC2-11QY08803 2020年11月25日 148Pages
    当調査資料は小児用ワクチンのグローバル市場について調査・分析したレポートです。種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他）市場規模、用途別（新生児、乳児、子供、思春期）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...
  • 小児用医薬品・ワクチンの世界市場（～2026年）
    Global Pediatric Drugs and Vaccines Market Insights and Forecast to 2026
    MRC2-11QY08800 2020年11月25日 146Pages
    当調査資料は小児用医薬品・ワクチンのグローバル市場について調査・分析したレポートです。種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、おたふく風邪、その他）市場規模、用途別（新生児、乳幼児、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • 早期陣痛治療の世界市場（～2026年）
    Global Preterm Labor Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04368 2020年11月20日 99Pages
    当調査資料は早期陣痛治療のグローバル市場について調査・分析したレポートです。種類別（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）市場規模、用途別（病院、小児科および新生児クリニック、ナーシングホーム、薬局）市場規模、地域別（...
  • 小児用身長測定ロッドの世界市場（～2026年）
    Global Pediatric Height Rods Market Insights and Forecast to 2026
    MRC2-11QY08801 2020年11月25日 146Pages
    当調査資料は小児用身長測定ロッドのグローバル市場について調査・分析したレポートです。種類別（移動型、卓上型、壁掛け型、床置き型）市場規模、用途別（病院、駅、幼稚園、家庭、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...
  • 小児脳腫瘍の世界市場（～2026年）小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
  • 小児放射線の世界市場（～2026年）小児放射線の世界市場（～2026年） Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults. The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. Market Analysis and Insights: Global Pediatric Radiology Marke…
  • 小児てんかん治療薬の世界市場（～2026年）小児てんかん治療薬の世界市場（～2026年） Epilepsy is one of the most common and challenging neurologic disorders affecting children. Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain. Market Analysis and Insights: Global Pediatric Epilep…
  • OTC小児医療の世界市場（～2026年）OTC小児医療の世界市場（～2026年） Over-The-Counter (OTC) medicines can be purchased without doctor’s prescription. OTC drugs are used to treat minor ailments and are usually consumed on basis of self-diagnosis. These drugs are available at pharmacies, small convenience stores as well as at supermarkets. OTC medication is usually not…
  • 小児画像の世界市場（～2026年）小児画像の世界市場（～2026年） Pediatric imaging is the application of imaging diagnostics in infants, children, their disease diagnosis, treatment, follow-up, and prevention of a discipline, is a sub-specialty of imaging diagnostics. Compared with other companies, Siemens Healthcare has the largest share of the global pediatric …